{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:20:53Z","timestamp":1778887253948,"version":"3.51.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11033-021-06363-4","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T10:13:30Z","timestamp":1619345610000},"page":"3827-3840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Toxic proteins application in cancer therapy"],"prefix":"10.1007","volume":"48","author":[{"given":"Zahra","family":"Setayesh-Mehr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdiye","family":"Poorsargol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,25]]},"reference":[{"issue":"11","key":"6363_CR1","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/toxins2112519","volume":"2","author":"A Shapira","year":"2010","unstructured":"Shapira A, Benhar I (2010) Toxin-based therapeutic approaches. Toxins 2(11):2519\u20132583. https:\/\/doi.org\/10.3390\/toxins2112519","journal-title":"Toxins"},{"issue":"24","key":"6363_CR2","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.1016\/S0021-9258(18)60855-5","volume":"262","author":"JM Maraganore","year":"1987","unstructured":"Maraganore JM, Joseph M, Bailey MC (1987) Purification and characterization of trichosanthin. Homology to the ricin A chain and implications as to mechanism of abortifacient activity. J Biol Chem 262(24):11628\u201311633. https:\/\/doi.org\/10.1016\/S0021-9258(18)60855-5","journal-title":"J Biol Chem"},{"issue":"8","key":"6363_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/toxins10080335","volume":"10","author":"WW Shi","year":"2018","unstructured":"Shi WW, Wong KB, Shaw PC (2018) Structural and functional investigation and pharmacological mechanism of trichosanthin, a type 1 ribosome-inactivating protein. Toxins 10(8):335. https:\/\/doi.org\/10.3390\/toxins10080335","journal-title":"Toxins"},{"issue":"3","key":"6363_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1042\/bj3550653","volume":"355","author":"C Zhang","year":"2001","unstructured":"Zhang C, Gong Y, Ma H, An C, Chen ZL (2001) Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells. Biochem J 355(3):653\u2013661. https:\/\/doi.org\/10.1042\/bj3550653","journal-title":"Biochem J"},{"issue":"6","key":"6363_CR5","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/ar.21142","volume":"293","author":"M Li","year":"2010","unstructured":"Li M, Li X, Li JC (2010) Possible mechanisms of trichosanthin-induced apoptosis of tumor cells. Anat Rec 293(6):986\u2013992. https:\/\/doi.org\/10.1002\/ar.21142","journal-title":"Anat Rec"},{"issue":"6","key":"6363_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00280-013-2096-y","volume":"71","author":"O Sha","year":"2013","unstructured":"Sha O, Niu J, Ng TB, Cho EYP, Fu X, Jiang W (2013) Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review. Cancer Chemother Pharmacol 71(6):1387\u20131393. https:\/\/doi.org\/10.1007\/s00280-013-2096-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"28","key":"6363_CR7","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.2174\/092986711797200499","volume":"18","author":"F Fang","year":"2011","unstructured":"Fang F, Ng T, ShawNSWong CPR (2011) Recent progress in medicinal investigations on trichosanthin and other ribosome inactivating proteins from the plant genus Trichosanthes. Curr Med Chem 18(28):4410\u20134417. https:\/\/doi.org\/10.2174\/092986711797200499","journal-title":"Curr Med Chem"},{"issue":"2\u20133","key":"6363_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tox.2006.11.074","volume":"231","author":"Z Li","year":"2007","unstructured":"Li Z, Qu Y, Li H, Yuan J (2007) Truncations of gelonin lead to a reduction in its cytotoxicity. Toxicology 231(2\u20133):129\u2013136. https:\/\/doi.org\/10.1016\/j.tox.2006.11.074","journal-title":"Toxicology"},{"issue":"5","key":"6363_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10565-008-9102-x","volume":"25","author":"P Wang","year":"2009","unstructured":"Wang P, Chen LL, Yan H, Li JC (2009) Trichosanthin suppresses HeLa cell proliferation through inhibition of the PKC\/MAPK signaling pathway. Cell Biol Toxicol 25(5):479\u2013488. https:\/\/doi.org\/10.1007\/s10565-008-9102-x","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"6363_CR10","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s11033-010-0432-4","volume":"38","author":"Q Jiang","year":"2010","unstructured":"Jiang Q, Bai T, Shen S, Li L, Ding H, Wang P (2010) Increase of cytosolic calcium induced by trichosanthin suppresses cAMP\/PKC levels through the inhibition of adenylyl cyclase activity in HeLa cells. Mol Biol Rep 38(4):2863\u20132868. https:\/\/doi.org\/10.1007\/s11033-010-0432-4","journal-title":"Mol Biol Rep"},{"issue":"3","key":"6363_CR11","first-page":"675","volume":"18","author":"M Kang","year":"2013","unstructured":"Kang M, Ou H, Wang R, Liu W, Mao Y, Tang A (2013) Effect of trichosanthin on apoptosis and telomerase activity of nasopharyngeal carcinomas in nude mice. J BUON 18(3):675\u2013682","journal-title":"J BUON"},{"issue":"4","key":"6363_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3892\/mmr.2012.994","volume":"6","author":"Y Huang","year":"2012","unstructured":"Huang Y, Song H, Hu H, Cui L, You C, Huang L (2012) Trichosanthin inhibits DNA methyltransferase and restores methylation-silenced gene expression in human cervical cancer cells. Mol Med Rep 6(4):872\u2013878. https:\/\/doi.org\/10.3892\/mmr.2012.994","journal-title":"Mol Med Rep"},{"key":"6363_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biopha.2014.10.027","volume":"69","author":"L Lei","year":"2015","unstructured":"Lei L, Song J, Wu L, Huang L, Wang Y, Huang Y, Yu H, Huang Y, You C, Ye J (2015) Smac is another pathway in the anti-tumour activity of trichosanthin and reverses trichosanthin resistance in CaSki cervical cancer cells. Biomed Pharmacother 69:119\u2013124. https:\/\/doi.org\/10.1016\/j.biopha.2014.10.027","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"6363_CR14","first-page":"239","volume":"8","author":"GF Chen","year":"2006","unstructured":"Chen GF, Huang WG, Chen FY, Shan JL (2006) Protective effects of trichosanthin in Herpes simplex virus-1 encephalitis in mice. Zhongguo Dang dai er ke za zhi= Chinese Journal of Contemporary Pediatrics 8(3):239\u2013241","journal-title":"Zhongguo Dang dai er ke za zhi= Chinese Journal of Contemporary Pediatrics"},{"issue":"9","key":"6363_CR15","doi-asserted-by":"publisher","first-page":"e41592","DOI":"10.1371\/journal.pone.0041592","volume":"7","author":"EF Fang","year":"2012","unstructured":"Fang EF, Zhang CZY, Zhang L, Wong JH, Chan YS, Pan WL, Dan XL, Yin CM, Cho CH, Ng TB (2012) Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis. PLoS ONE 7(9):e41592. https:\/\/doi.org\/10.1371\/journal.pone.0041592","journal-title":"PLoS ONE"},{"issue":"2","key":"6363_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0014-5793(02)03539-1","volume":"531","author":"JH Wang","year":"2002","unstructured":"Wang JH, Nie HL, Tam SC, Huang H, Zheng YT (2002) Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity. FEBS Lett 531(2):295\u2013298. https:\/\/doi.org\/10.1016\/S0014-5793(02)03539-1","journal-title":"FEBS Lett"},{"issue":"14","key":"6363_CR17","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1016\/S0021-9258(18)43667-8","volume":"255","author":"F Stirpe","year":"1980","unstructured":"Stirpe F, Olsnes S, Pihl A (1980) Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. J Biol Chem 255(14):6947\u20136953. https:\/\/doi.org\/10.1016\/S0021-9258(18)43667-8","journal-title":"J Biol Chem"},{"issue":"8","key":"6363_CR18","first-page":"1971","volume":"4","author":"MG Rosenblum","year":"1976","unstructured":"Rosenblum MG (1976) Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity. Clin Cancer Res 4(8):1971\u20131976","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6363_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","volume":"151","author":"AK Varkouhi","year":"2011","unstructured":"Varkouhi AK, Scholte M, Storm G, Haisma HJ (2011) Endosomal escape pathways for delivery of biologicals. J Control Release 151(3):220\u2013228. https:\/\/doi.org\/10.1016\/j.jconrel.2010.11.004","journal-title":"J Control Release"},{"issue":"1\u20132","key":"6363_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s0014-5793(97)00267-6","volume":"406","author":"E Nicolas","year":"1997","unstructured":"Nicolas E, Beggs JM, Haltiwanger BM, Taraschi TF (1997) Direct evidence for the deoxyribonuclease activity of the plant ribosome inactivating protein gelonin. FEBS Lett 406(1\u20132):162\u2013164. https:\/\/doi.org\/10.1016\/s0014-5793(97)00267-6","journal-title":"FEBS Lett"},{"issue":"1","key":"6363_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jconrel.2013.08.016","volume":"172","author":"MC Shin","year":"2013","unstructured":"Shin MC, Zhang J, David AE, Trommer WE, Kwon YM, Min KA, Kim JH, Yang VC (2013) Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. J Control Release 172(1):169\u2013178. https:\/\/doi.org\/10.1016\/j.jconrel.2013.08.016","journal-title":"J Control Release"},{"issue":"2","key":"6363_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0378-1119(93)90097-m","volume":"134","author":"PA Nolan","year":"1993","unstructured":"Nolan PA, Garrison DA, Better M (1993) Cloning and expression of a gene encoding gelonin, a ribosome-inactivating protein from Gelonium multiflorum. Gene 134(2):223\u2013227. https:\/\/doi.org\/10.1016\/0378-1119(93)90097-m","journal-title":"Gene"},{"issue":"9","key":"6363_CR23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/1061186X.2018.1516221","volume":"27","author":"LC Pagliaro","year":"2019","unstructured":"Pagliaro LC, Liu B, Munker R, Andreeff M, Freireich EJ, Scheinberg DA, Park T, Min KA, Cheong H, Moon C, Shin MC (2019) Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy. J Drug Target 27(9):950\u2013958. https:\/\/doi.org\/10.1080\/1061186X.2018.1516221","journal-title":"J Drug Target"},{"issue":"12","key":"6363_CR24","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1073\/pnas.122157899","volume":"99","author":"LM Veenendaal","year":"2002","unstructured":"Veenendaal LM, Jin H, Ran S, Cheung L, Navone N, Marks JW, Waltenberger J, Thorpe P, Rosenblum MG (2002) In vitro and in vivo studies of a VEGF121\/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors. Proc Natl Acad Sci 99(12):7866\u20137871. https:\/\/doi.org\/10.1073\/pnas.122157899","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"6363_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/1535-7163.MCT-06-0254","volume":"6","author":"MA Lyu","year":"2007","unstructured":"Lyu MA, Cheung LH, Hittelman WN, Marks JW, Aguiar RC, Rosenblum MG (2007) The rGel\/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA. Mol Cancer Ther 6(2):460\u2013470. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0254","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"6363_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1593\/neo.91960","volume":"12","author":"MA Lyu","year":"2010","unstructured":"Lyu MA, Rai D, Ahn KS, Sung B, Cheung LH, Marks JW, Aggarwal BB, Aguiar RCT, Gandhi V, Rosenblum MG (2010) The rGel\/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo. Neoplasia 12(5):366\u2013375. https:\/\/doi.org\/10.1593\/neo.91960","journal-title":"Neoplasia"},{"issue":"6","key":"6363_CR27","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood-2006-08-042424","volume":"109","author":"R Nimmanapalli","year":"2007","unstructured":"Nimmanapalli R, Lyu M, Du M, Keating MJ, Rosenblum MG, Gandhi V (2007) The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R\u2013positive CLL cells. Blood 109(6):2557\u20132564. https:\/\/doi.org\/10.1182\/blood-2006-08-042424","journal-title":"Blood"},{"key":"6363_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-12-416039-2.00008-2","volume":"502","author":"MA Lyu","year":"2012","unstructured":"Lyu MA, Cao YJ, Mohamedali KA, Rosenblum MG (2012) Cell-targeting fusion constructs containing recombinant gelonin. Methods Enzymol 502:167\u2013214. https:\/\/doi.org\/10.1016\/B978-0-12-416039-2.00008-2","journal-title":"Methods Enzymol"},{"issue":"9","key":"6363_CR29","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s12272-017-0953-7","volume":"40","author":"S Ham","year":"2017","unstructured":"Ham S, Min KA, Yang JW, Shin MC (2017) Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy. Arch Pharm Res 40(9):1094\u20131104. https:\/\/doi.org\/10.1007\/s12272-017-0953-7","journal-title":"Arch Pharm Res"},{"issue":"9","key":"6363_CR30","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s11095-016-1959-4","volume":"33","author":"MC Shin","year":"2016","unstructured":"Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC (2016) Preparation and characterization of gelonin-melittin fusion biotoxin for synergistically enhanced anti-tumor activity. Pharm Res 33(9):2218\u20132228. https:\/\/doi.org\/10.1007\/s11095-016-1959-4","journal-title":"Pharm Res"},{"issue":"6","key":"6363_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/aps.2017.20","volume":"38","author":"SH Ham","year":"2017","unstructured":"Ham SH, Min KA, Shin MC (2017) Molecular tumor targeting of gelonin by fusion with F3 peptide. Acta Pharmacol Sin 38(6):897\u2013906. https:\/\/doi.org\/10.1038\/aps.2017.20","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"6363_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1124\/pr.114.009001","volume":"67","author":"C Esser","year":"2015","unstructured":"Esser C, Rannug A (2015) The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol Rev 67(2):259\u2013279. https:\/\/doi.org\/10.1124\/pr.114.009001","journal-title":"Pharmacol Rev"},{"issue":"7","key":"6363_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.resmic.2009.06.004","volume":"160","author":"A Pohorille","year":"2009","unstructured":"Pohorille A, Deamer D (2009) Self-assembly and function of primitive cell membranes. Res Microbiol 160(7):449\u2013456. https:\/\/doi.org\/10.1016\/j.resmic.2009.06.004","journal-title":"Res Microbiol"},{"key":"6363_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.nano.2019.02.006","volume":"17","author":"K Khanmohammadi Chenab","year":"2019","unstructured":"Khanmohammadi Chenab K, Eivazzadeh-Keihan R, Pashazadeh-Panahi P, Rhamblin M, Mokhtarzadeh A (2019) Biomedical applications of nanoflares: targeted intracellular fluorescence probes. Nanomed Nanotechnol Biol Med 17:342\u2013358","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"6363_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.addr.2019.06.008","volume":"143","author":"C Su","year":"2019","unstructured":"Su C, Liu Y, Li R, Wu W, Fawcett JP, Gu J (2019) Absorption, distribution, metabolism and excretion of the biomaterials used in nanocarrier drug delivery systems. Adv Drug Deliv Rev 143:97\u2013114. https:\/\/doi.org\/10.1016\/j.addr.2019.06.008","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"6363_CR36","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","volume":"24","author":"AR Jones","year":"2007","unstructured":"Jones AR, Shusta EV (2007) Blood\u2013brain barrier transport of therapeutics via receptor-mediation. Pharm Res 24(9):1759\u20131771. https:\/\/doi.org\/10.1007\/s11095-007-9379-0","journal-title":"Pharm Res"},{"key":"6363_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/869269","author":"RK Upadhyay","year":"2014","unstructured":"Upadhyay RK (2014) Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int. https:\/\/doi.org\/10.1155\/2014\/869269","journal-title":"Biomed Res Int"},{"issue":"6_suppl_2","key":"6363_CR38","first-page":"S25","volume":"109","author":"KP High","year":"2009","unstructured":"High KP (2009) Overcoming barriers to adult immunization. J Am Osteopath Assoc 109(6_suppl_2):S25\u2013S28","journal-title":"J Am Osteopath Assoc"},{"issue":"1","key":"6363_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1006\/bbrc.2001.4940","volume":"284","author":"W Xu","year":"2001","unstructured":"Xu W, Hou W, Yao G, Ji Y, Yeh M, Sun B (2001) Inhibition of Th1-and enhancement of Th2-initiating cytokines and chemokines in trichosanthin-treated macrophages. Biochem Biophys Res Commun 284(1):168\u2013172. https:\/\/doi.org\/10.1006\/bbrc.2001.4940","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"6363_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0014-4827(92)90148-2","volume":"198","author":"S Madan","year":"1992","unstructured":"Madan S, Ghosh PC (1992) Interaction of gelonin with macrophages: effect of lysosomotropic amines. Exp Cell Res 198(1):52\u201358. https:\/\/doi.org\/10.1016\/0014-4827(92)90148-2","journal-title":"Exp Cell Res"},{"issue":"34","key":"6363_CR41","doi-asserted-by":"publisher","first-page":"13515","DOI":"10.1073\/pnas.1210182109","volume":"109","author":"IK Zervantonakis","year":"2012","unstructured":"Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, Kamm RD (2012) Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci 109(34):13515\u201313520. https:\/\/doi.org\/10.1073\/pnas.1210182109","journal-title":"Proc Natl Acad Sci"},{"key":"6363_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fonc.2013.00211","volume":"3","author":"S Azzi","year":"2013","unstructured":"Azzi S, Hebda JK, Gavard J (2013) Vascular permeability and drug delivery in cancers. Front Oncol 3:211. https:\/\/doi.org\/10.3389\/fonc.2013.00211","journal-title":"Front Oncol"},{"issue":"6","key":"6363_CR43","doi-asserted-by":"publisher","first-page":"e40006","DOI":"10.1371\/journal.pone.0040006","volume":"7","author":"TG Simonsen","year":"2012","unstructured":"Simonsen TG, Gaustad JV, Leinaas MN, Rofstad EK (2012) High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts. PLoS ONE 7(6):e40006. https:\/\/doi.org\/10.1371\/journal.pone.0040006","journal-title":"PLoS ONE"},{"issue":"10","key":"6363_CR44","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/ijms19103028","volume":"19","author":"C Walker","year":"2018","unstructured":"Walker C, Mojares E, del R\u00edo HA (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci 19(10):3028. https:\/\/doi.org\/10.3390\/ijms19103028","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6363_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10585-019-09966-1","volume":"36","author":"JA Eble","year":"2019","unstructured":"Eble JA, Niland S (2019) The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis 36(1):1\u201328. https:\/\/doi.org\/10.1007\/s10585-019-09966-1","journal-title":"Clin Exp Metastasis"},{"key":"6363_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.addr.2015.12.002","volume":"97","author":"JLS Au","year":"2016","unstructured":"Au JLS, Yeung BZ, Wientjes MG, Lu Z, Wientjes MG (2016) Delivery of cancer therapeutics to extracellular and intracellular targets: determinants, barriers, challenges and opportunities. Adv Drug Deliv Rev 97:280\u2013301. https:\/\/doi.org\/10.1016\/j.addr.2015.12.002","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"6363_CR47","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.7150\/thno.16358","volume":"6","author":"B Chen","year":"2016","unstructured":"Chen B, Le W, Wang Y, Li Z, Wang D, Ren L, Lin L, Cui S, Hu JJ, Hu Y (2016) Targeting negative surface charges of cancer cells by multifunctional nanoprobes. Theranostics 6(11):1887\u20131898. https:\/\/doi.org\/10.7150\/thno.16358","journal-title":"Theranostics"},{"issue":"9","key":"6363_CR48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrm2755","volume":"10","author":"BD Grant","year":"2009","unstructured":"Grant BD, Donaldson JG (2009) Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 10(9):597\u2013608. https:\/\/doi.org\/10.1038\/nrm2755","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"6363_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jbm.a.34859","volume":"102","author":"MC Shin","year":"2014","unstructured":"Shin MC, Zhang J, Min KA, Lee K, Byun Y, David AE, He H, Yang VC (2014) Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A 102(2):575\u2013587. https:\/\/doi.org\/10.1002\/jbm.a.34859","journal-title":"J Biomed Mater Res A"},{"issue":"4","key":"6363_CR50","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/1389450118666170302094758","volume":"19","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang M, Min KA, Wang H, Shin MC, Li F, Yang VC, Huang Y (2018) Improved protein toxin delivery based on ATTEMPTS systems. Curr Drug Targets 19(4):380\u2013392. https:\/\/doi.org\/10.2174\/1389450118666170302094758","journal-title":"Curr Drug Targets"},{"issue":"4","key":"6363_CR51","doi-asserted-by":"publisher","first-page":"17R","DOI":"10.1093\/glycob\/cwh051","volume":"14","author":"AK Powell","year":"2004","unstructured":"Powell AK, Yates EA, Fernig DG, Turnbull JE (2004) Interactions of heparin\/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology 14(4):17R-30R. https:\/\/doi.org\/10.1093\/glycob\/cwh051","journal-title":"Glycobiology"},{"issue":"1","key":"6363_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7150\/ntno.18292","volume":"1","author":"H Wang","year":"2017","unstructured":"Wang H, Moon C, Shin MC, Wang Y, He H, Yang VC, Huang Y (2017) Heparin-regulated prodrug-type macromolecular theranostic systems for cancer therapy. Nanotheranostics 1(1):114. https:\/\/doi.org\/10.7150\/ntno.18292","journal-title":"Nanotheranostics"},{"issue":"8","key":"6363_CR53","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s11095-015-1653-y","volume":"32","author":"MC Shin","year":"2015","unstructured":"Shin MC, Zhang J, Min KA, He H, David AE, Huang Y, Yang VC (2015) PTD-modified ATTEMPTS for enhanced toxin-based cancer therapy: an in vivo proof-of-concept study. Pharm res 32(8):2690\u20132703. https:\/\/doi.org\/10.1007\/s11095-015-1653-y","journal-title":"Pharm res"},{"issue":"1","key":"6363_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jbm.a.35188","volume":"103","author":"MC Shin","year":"2015","unstructured":"Shin MC, Zhao J, Zhang J, Huang Y, He H, Wang M, Min KA, Yang VC (2015) Recombinant TAT\u2013gelonin fusion toxin: synthesis and characterization of heparin\/protamine-regulated cell transduction. J Biomed Mater Res A 103(1):409\u2013419. https:\/\/doi.org\/10.1002\/jbm.a.35188","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"6363_CR55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jbm.a.35188","volume":"103","author":"MC Shin","year":"2015","unstructured":"Shin MC, Zhao J, Zhang J, Huang Y, He H, Wang M, Ah Min K, Yang VC (2015) Recombinant TAT\u2013gelonin fusion toxin: synthesis and characterization of heparin\/protamine-regulated cell transduction. J Biomed Mater Res A 103(1):409\u2013419","journal-title":"J Biomed Mater Res A"},{"issue":"14","key":"6363_CR56","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.7150\/thno.20578","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang M, Jin H, Li D, Xu F, Wu A, Wang J, Huang Y (2017) Glioma dual-targeting nanohybrid protein toxin constructed by intein-mediated site-specific ligation for multistage booster delivery. Theranostics 7(14):3489. https:\/\/doi.org\/10.7150\/thno.20578","journal-title":"Theranostics"},{"key":"6363_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biomaterials.2016.11.033","volume":"116","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang M, Jin H, Tang Y, Wang H, Xu Q, Li Y, Li F, Huang Y (2017) Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: turning PEG dilemma into prodrug-like feature. Biomaterials 116:57\u201368. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.11.033","journal-title":"Biomaterials"},{"issue":"5","key":"6363_CR58","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1021\/acs.molpharmaceut.6b00987","volume":"14","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang M, Jin H, Tang Y, Wu A, Xu Q, Hunag Y (2017) Prodrug-like, PEGylated protein toxin trichosanthin for reversal of chemoresistance. Mol Pharm 14(5):1429\u20131438. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00987","journal-title":"Mol Pharm"},{"issue":"1","key":"6363_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-13-89","volume":"13","author":"Y Kato","year":"2013","unstructured":"Kato Y, Ozawa S, Miyamoto C, Maehata Y, Suzuki A, Maeda T, Baba Y (2013) Acidic extracellular microenvironment and cancer. Cancer Cell Int 13(1):1\u20138. https:\/\/doi.org\/10.1186\/1475-2867-13-89","journal-title":"Cancer Cell Int"},{"issue":"20","key":"6363_CR60","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1158\/1078-0432.CCR-15-1502","volume":"21","author":"YK Reshetnyak","year":"2015","unstructured":"Reshetnyak YK (2015) Imaging tumor acidity: pH-low insertion peptide probe for optoacoustic tomography. Clin Cancer Res 21(20):4502\u20134504. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1502","journal-title":"Clin Cancer Res"},{"issue":"12","key":"6363_CR61","doi-asserted-by":"publisher","first-page":"125112","DOI":"10.1088\/2053-1591\/ab657b","volume":"6","author":"K Khanmohammadi Chenab","year":"2020","unstructured":"Khanmohammadi Chenab K, Sohrabi B, Esrafili M (2020) pH-sensitive organic diimide materials-based superhydrophobic surface for oil-water separation applications. Mater Res Express 6(12):125112","journal-title":"Mater Res Express"},{"key":"6363_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2016.07.024","volume":"238","author":"M Vila-Caballer","year":"2016","unstructured":"Vila-Caballer M, Codolo G, Munari F, Malfanti A, Fassan M, Rugge M, Balasso A, de Bernard M, Salmaso S (2016) A pH-sensitive stearoyl-PEG-poly (methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: an application for bladder cancer treatment. J Control Release 238:31\u201342. https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.024","journal-title":"J Control Release"},{"issue":"1","key":"6363_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42231","volume":"7","author":"M Kisovec","year":"2017","unstructured":"Kisovec M, Rezelj S, Knap P, Cajnko MM, Caserman S, Fla\u0161ker A, \u017dnidar\u0161i\u010d N, Repi\u010d M, Mavri J, Ruan Y (2017) Engineering a pH responsive pore forming protein. Sci Rep 7(1):1\u201313. https:\/\/doi.org\/10.1038\/srep42231","journal-title":"Sci Rep"},{"key":"6363_CR64","doi-asserted-by":"publisher","first-page":"100262","DOI":"10.1016\/j.mtchem.2020.100262","volume":"16","author":"K Khanmohammadi Chenab","year":"2020","unstructured":"Khanmohammadi Chenab K, Sohrabi B, Jafari A, Ramakrishna S (2020) Water treatment: functional nanomaterials and applications from adsorption to photodegradation. Mater Today Chem 16:100262. https:\/\/doi.org\/10.1016\/j.mtchem.2020.100262","journal-title":"Mater Today Chem"},{"key":"6363_CR65","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molstruc.2018.05.014","volume":"1167","author":"K Khanmohammadi Chenab","year":"2018","unstructured":"Khanmohammadi Chenab K, Sohrabi B, Jafari A, Ramakrishna S (2018) Effect of electron-donating and -withdrawing substitutions in naphthoquinone sensitizers: the structure engineering of dyes for DSSCs. J Mol Struct 1167:274\u2013279. https:\/\/doi.org\/10.1016\/j.molstruc.2018.05.014","journal-title":"J Mol Struct"},{"issue":"8","key":"6363_CR66","doi-asserted-by":"publisher","first-page":"085537","DOI":"10.1088\/2053-1591\/ab2500","volume":"6","author":"K Khanmohammadi Chenab","year":"2019","unstructured":"Khanmohammadi Chenab K, Sohrabi B, Zamani Meymian MR, Mousavi SV (2019) Naphthoquinone derivative-based dye for dye-sensitized solar cells: experimental and computational aspects. Mater Res Express 6(8):085537","journal-title":"Mater Res Express"},{"issue":"12","key":"6363_CR67","doi-asserted-by":"publisher","first-page":"125536","DOI":"10.1088\/2053-1591\/ab61c0","volume":"6","author":"K Khanmohammadi Chenab","year":"2020","unstructured":"Khanmohammadi Chenab K, Sohrabi B, Zamani Meymian MR (2020) Cobalt complex dye as a novel sensitizer in dye sensitized solar cells. Mater Res Express 6(12):125536","journal-title":"Mater Res Express"},{"issue":"21","key":"6363_CR68","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1021\/acs.langmuir.0c00093","volume":"36","author":"K Khanmohammadi Chenab","year":"2020","unstructured":"Khanmohammadi Chenab K (2020) (2020) Anti-Icing Properties of vertically aligned TiO2 nanopillars. Langmuir 36(21):6041\u20136050. https:\/\/doi.org\/10.1021\/acs.langmuir.0c00093","journal-title":"Langmuir"},{"issue":"185","key":"6363_CR69","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jare.2019.03.011","volume":"18","author":"R Eivazzadeh-Keihan","year":"2019","unstructured":"Eivazzadeh-Keihan R, Maleki A, del la Guardia M, Salimi Bani M, Khanmohammadi Chenab K, Pashazadeh-Panahi M, Baradaran B, Mokhtarzadeh A, Hamblim MR (2019) Carbon based nanomaterials for tissue engineering of bone: building new bone on small black scaffolds: a review. J Adv Res 18(185):201. https:\/\/doi.org\/10.1016\/j.jare.2019.03.011","journal-title":"J Adv Res"},{"key":"6363_CR70","doi-asserted-by":"publisher","first-page":"110267","DOI":"10.1016\/j.msec.2019.110267","volume":"107","author":"R Eivazzadeh-Keihan","year":"2020","unstructured":"Eivazzadeh-Keihan R, Maleki A, del la Guardia M, Salimi Bani M, Khanmohammadi Chenab K, Pashazadeh-Panahi M, Baradaran B, Mokhtarzadeh A, Hamblim MR (2020) Recent advances in the application of mesoporous silica-based nanomaterials for bone tissue engineering. Mater Sci Eng 107:110267. https:\/\/doi.org\/10.1016\/j.msec.2019.110267","journal-title":"Mater Sci Eng"},{"issue":"12","key":"6363_CR71","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/term.3131","volume":"14","author":"R Eivazzadeh-Keihan","year":"2020","unstructured":"Eivazzadeh-Keihan R, Bahojb Noruzi E, Khanmohammadi Chenab K, Jafari A, Radinekiyan F, Hashemi SM, Behboudi A, Mosafer J, Mokhtarzadeh A, Maleki A, Hamblin MR (2020) Metal-based nanoparticles for bone tissue engineering. J Tissue Eng Regen Med 14(12):1687\u20131714. https:\/\/doi.org\/10.1002\/term.3131","journal-title":"J Tissue Eng Regen Med"},{"issue":"8","key":"6363_CR72","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1039\/C9BM00558G","volume":"7","author":"K Khanmohammadi Chenab","year":"2019","unstructured":"Khanmohammadi Chenab K, Sohrabi B, Rahmanzadeh A (2019) Superhydrophobicity: advanced biological and biomedical applications. Biomater Sci 7(8):3110\u20133137","journal-title":"Biomater Sci"},{"issue":"3","key":"6363_CR73","doi-asserted-by":"publisher","first-page":"212","DOI":"10.20892\/j.issn.2095-3941.2017.0054","volume":"14","author":"M Zhang","year":"2017","unstructured":"Zhang M, Liu E, Cui Y, Huang Y (2017) Nanotechnology based combination therapy for overcoming multidrug resistant cancer. Cancer Biol Med. 14(3):212. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2017.0054","journal-title":"Cancer Biol Med."},{"issue":"1","key":"6363_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-016-0272-1","volume":"23","author":"E Pizzo","year":"2016","unstructured":"Pizzo E, Di Maro A (2016) A new age for biomedical applications of ribosome inactivating proteins (RIPs): from bioconjugate to nanoconstructs. J Biomed Sci 23(1):1\u20138","journal-title":"J Biomed Sci"},{"issue":"37","key":"6363_CR75","doi-asserted-by":"publisher","first-page":"35102","DOI":"10.1074\/jbc.M305411200","volume":"278","author":"CJ Provoda","year":"2003","unstructured":"Provoda CJ, Stier EM, Lee KD (2003) Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin. J Biol Chem 278(37):35102\u201335108. https:\/\/doi.org\/10.1074\/jbc.M305411200","journal-title":"J Biol Chem"},{"issue":"32","key":"6363_CR76","doi-asserted-by":"publisher","first-page":"26648","DOI":"10.1021\/acsami.7b05292","volume":"9","author":"Y Tang","year":"2017","unstructured":"Tang Y, Liang J, Wu A, Chen Y, Zhao P, Lin T, Zhang M, Xu Q, Wang J, Huang Y (2017) Co-delivery of trichosanthin and albendazole by nano-self-assembly for overcoming tumor multidrug-resistance and metastasis. ACS Appl Mater Interfaces 9(32):26648\u201326664. https:\/\/doi.org\/10.1021\/acsami.7b05292","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"6363_CR77","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/ijc.29510","volume":"138","author":"M de Pinillos","year":"2016","unstructured":"de Pinillos M, Bayona A, Moore CM, Loizidou M, MacRobert AJ, Woodhams JH (2016) Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation. Int J Cancer 138(5):1049\u20131057. https:\/\/doi.org\/10.1002\/ijc.29510","journal-title":"Int J Cancer"},{"issue":"14","key":"6363_CR78","doi-asserted-by":"publisher","first-page":"12436","DOI":"10.18632\/oncotarget.3814","volume":"6","author":"B Bull-Hansen","year":"2015","unstructured":"Bull-Hansen B, Berstad MB, Berg K, Cao Y, Skarpen E, Fremstedal AS, Rosenblum MG, Peng Q, Weyergang A (2015) Photochemical activation of MH3-B1\/rGel: a HER2-targeted treatment approach for ovarian cancer. Oncotarget 6(14):12436. https:\/\/doi.org\/10.18632\/oncotarget.3814","journal-title":"Oncotarget"},{"issue":"44","key":"6363_CR79","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1038\/onc.2015.15","volume":"34","author":"M Berstad","year":"2015","unstructured":"Berstad M, Cheung L, Berg K, Peng Q, Fremstedal A, Patzke S, Rosenblum MG, Weyergang A (2015) Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy. Oncogene 34(44):5582\u20135592. https:\/\/doi.org\/10.1038\/onc.2015.15","journal-title":"Oncogene"},{"issue":"11","key":"6363_CR80","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1038\/sj.bjc.6602600","volume":"92","author":"A Dietze","year":"2005","unstructured":"Dietze A, Peng Q, Selbo PK, Kaalhus O, M\u00fcller C, Bown S, Berg K (2005) Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. Br J Cancer 92(11):2004","journal-title":"Br J Cancer"},{"issue":"6","key":"6363_CR81","first-page":"1180","volume":"59","author":"K Berg","year":"1999","unstructured":"Berg K, Selbo PK, Prasmickaite L, Tjelle TE, Sandvig K, Moan J, Gaudernack G, Fodstad \u00d8, Kj\u00f8lsrud S, Anholt H (1999) Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer res 59(6):1180\u20131183","journal-title":"Cancer res"},{"key":"6363_CR82","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jconrel.2018.09.005","volume":"288","author":"A Weyergang","year":"2018","unstructured":"Weyergang A, Fremstedal AS, Skarpen E, Peng Q, Mohamedali KA, Eng MS, Cheung LH, Rosenblum MG, Waltenberger J, Berg K (2018) Light-enhanced VEGF121\/rGel: a tumor targeted modality with vascular and immune-mediated efficacy. J Control Release 288:161\u2013172. https:\/\/doi.org\/10.1016\/j.jconrel.2018.09.005","journal-title":"J Control Release"},{"issue":"4","key":"6363_CR83","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/pr.57.4.4","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall WA, Goldin AL, Waxman SG (2005) International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 57(4):397\u2013409. https:\/\/doi.org\/10.1124\/pr.57.4.4","journal-title":"Pharmacol Rev"},{"issue":"1","key":"6363_CR84","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev.bi.64.070195.002425","volume":"6","author":"WA Catterall","year":"1995","unstructured":"Catterall WA (1995) Structure and function of voltage-gated ion channels. Annu Rev Biochem 6(1):493\u2013531. https:\/\/doi.org\/10.1146\/annurev.bi.64.070195.002425","journal-title":"Annu Rev Biochem"},{"issue":"7356","key":"6363_CR85","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature10238","volume":"475","author":"J Payandeh","year":"2011","unstructured":"Payandeh J, Scheuer T, Zheng N, Catterall WA (2011) The crystal structure of a voltage-gated sodium channel. Nature 475(7356):353\u2013358. https:\/\/doi.org\/10.1038\/nature10238","journal-title":"Nature"},{"issue":"12","key":"6363_CR86","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.3390\/md11124698","volume":"11","author":"F Zhang","year":"2013","unstructured":"Zhang F, Xu X, Li T, Liu Z (2013) Shellfish toxins targeting voltage-gated sodium channels. Mar Drugs 11(12):4698\u20134723. https:\/\/doi.org\/10.3390\/md11124698","journal-title":"Mar Drugs"},{"issue":"9\u201310","key":"6363_CR87","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3389\/fphar.2011.00071","volume":"82","author":"S Cest\u00e8le","year":"2000","unstructured":"Cest\u00e8le S, Catterall WA (2000) Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 82(9\u201310):883\u2013892. https:\/\/doi.org\/10.3389\/fphar.2011.00071","journal-title":"Biochimie"},{"issue":"10","key":"6363_CR88","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd1197","volume":"2","author":"RJ Lewis","year":"2003","unstructured":"Lewis RJ, Garcia ML (2003) Therapeutic potential of venom peptides. Nat Rev Drug Discov 2(10):790\u2013802. https:\/\/doi.org\/10.1038\/nrd1197","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"6363_CR89","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2174\/1568026615666150217110710","volume":"15","author":"S Luz Morales-Lazaro","year":"2015","unstructured":"Luz Morales-Lazaro S, Hern\u00e1ndez-Garc\u00eda E, Serrano-Flores B, Rosenbaum T (2015) Organic toxins as tools to understand ion channel mechanisms and structure. Curr Top Med Chem 15(7):581\u2013603. https:\/\/doi.org\/10.2174\/1568026615666150217110710","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"6363_CR90","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2174\/092986712798992039","volume":"19","author":"A Girault","year":"2012","unstructured":"Girault A, Haelters JP, Potier-Cartereau M, Chant\u00f4me A, Jaffres PA, Bougnoux P, Joulin V, Vandier C (2012) Targeting SKCa channels in cancer: potential new therapeutic approaches. Curr Med Chem 19(5):697\u2013713. https:\/\/doi.org\/10.2174\/092986712798992039","journal-title":"Curr Med Chem"},{"issue":"11","key":"6363_CR91","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1158\/1535-7163.MCT-06-0194","volume":"5","author":"M Potier","year":"2006","unstructured":"Potier M, Joulin V, Roger S, Besson P, Jourdan ML, LeGuennec JY, Bougnoux P, Vandier C (2006) Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol Cancer Ther 5(11):2946\u20132953. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0194","journal-title":"Mol Cancer Ther"},{"key":"6363_CR92","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-pharmtox-010919-023420","volume":"60","author":"BM Brown","year":"2020","unstructured":"Brown BM, Shim H, Christophersen P, Wulff H (2020) Pharmacology of small-and intermediate-conductance calcium-activated potassium channels. Annu Rev Pharmacol Toxicol 60:219\u2013240. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010919-023420","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"6363_CR93","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2016.06.003","volume":"165","author":"PA Jaffres","year":"2016","unstructured":"Jaffres PA, Gajate C, Bouchet AM, Couthon-Gourves H, Chant\u00f4me A, Potier-Cartereau M, Besson P, Bougnoux P, Mollinedo F, Vandier C (2016) Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy. Pharmacol Ther 165:114\u2013131. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.06.003","journal-title":"Pharmacol Ther"},{"issue":"48","key":"6363_CR94","doi-asserted-by":"publisher","first-page":"46101","DOI":"10.1074\/jbc.M206465200","volume":"277","author":"P Pedarzani","year":"2002","unstructured":"Pedarzani P, D\u2019hoedt D, Doorty KB, Wadsworth JD, Joseph JS, Jeyaseelan K, Kini RM, Gadre S, Sapatnekar S, Stocker M (2002) Tamapin, a venom peptide from the Indian red scorpion (Mesobuthus tamulus) that targets small conductance Ca2+-activated K+ channels and after hyperpolarization currents in central neurons. J Biol Chem 277(48):46101\u201346109. https:\/\/doi.org\/10.1074\/jbc.M206465200","journal-title":"J Biol Chem"},{"issue":"8","key":"6363_CR95","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1021\/acsmedchemlett.0c00300","volume":"11","author":"M Mayorga-Flores","year":"2020","unstructured":"Mayorga-Flores M, Chant\u00f4me A, Melchor-Meneses CM, Domingo I, Titaux-Delgado GA, Galindo-Murillo R, Vandier C, del R\u00edo-Portilla F (2020) Novel blocker of onco SK3 channels derived from scorpion toxin tamapin and active against migration of cancer cells. ACS Med Chem Lett. 11(8):1627\u20131633. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00300","journal-title":"ACS Med Chem Lett."},{"issue":"41","key":"6363_CR96","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1021\/ja8042036","volume":"130","author":"C Li","year":"2008","unstructured":"Li C, Liu M, Monbo J, Zou G, Li C, Yuan W, Zella D, Lu WY, Lu W (2008) Turning a scorpion toxin into an antitumor miniprotein. J Am Chem Soc 130(41):13546\u201313548. https:\/\/doi.org\/10.1021\/ja8042036","journal-title":"J Am Chem Soc"},{"issue":"3","key":"6363_CR97","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1021\/jm101018r","volume":"54","author":"M Akcan","year":"2011","unstructured":"Akcan M, Stroud MR, Hansen SJ, Clark RJ, Daly NL, Craik DJ, Olson JM (2011) Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. J Med Chem 54(3):782\u2013787. https:\/\/doi.org\/10.1021\/jm101018r","journal-title":"J Med Chem"},{"issue":"6","key":"6363_CR98","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1529\/biophysj.103.039461","volume":"86","author":"K Yu","year":"2004","unstructured":"Yu K, Fu W, Liu H, Luo X, Chen KX, Ding J, Shen J, Jiang H (2004) Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel. Biophys J 86(6):3542\u20133555. https:\/\/doi.org\/10.1529\/biophysj.103.039461","journal-title":"Biophys J"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06363-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T12:30:19Z","timestamp":1622637019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06363-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6363"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06363-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"17 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Zahra Setayesh-Mehr and Mahdiye poorsargol declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}